Profile: Thermo Fisher Scientific Inc (TMO)
21 Oct 2016
Thermo Fisher Scientific Inc., incorporated on October 11, 1960, develops, manufactures and sells a range of products. The Company is a provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Company serves its customers through its brands, Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services. The Thermo Scientific brand offers customers in research, diagnostics, industrial and applied markets analytical instruments, as well as laboratory equipment, software, services, consumables and reagents.
The Company's Applied Biosystems brand offers customers in research, clinical and applied markets integrated instrument systems, reagents and software for genetic analysis. The Invitrogen brand offers life science customers a range of consumables and instruments that accelerate research and ensure consistency of results. Its portfolio of products includes solutions for cellular analysis and biology, flow cytometry, cell culture, protein expression, synthetic biology, molecular biology and protein biology. Fisher Scientific is its channels brand, offering a portfolio of laboratory equipment, chemicals, supplies and services used in scientific research, healthcare, safety and education markets. Unity Lab Services is its services brand, offering a portfolio of services from enterprise level engagements to individual instruments and laboratory equipment.
Life Sciences Solutions Segment
Through the Life Sciences Solutions segment, the Company provides reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines, as well as diagnosis of disease. These products and services are used by customers in pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. Life Sciences Solutions includes approximately three primary businesses: biosciences, genetic sciences and next-generation sequencing, and bioproduction. The biosciences business includes reagents, instruments and consumables used for protein biology, molecular biology, and cell imaging and analysis. The portfolio includes antibodies and products for protein purification, detection, modification, and analysis, and sequencing, detection and purification products used for high content analysis of nucleic acids. The biosciences business also includes tools used for genetic engineering, amplification, quantification and analysis, as well as ribonucleic acid (RNA) isolation, including stem cell reprogramming kits, transfection reagents, RNA interference reagents, along with gene editing tools and gene synthesis products; cell culture media and reagents for preserving and growing mammalian cells; fluorescence-based technologies, and protein analysis products, including pre-cast electrophoresis gels for separating nucleic acids and proteins, and western blotting and staining tools.
The Company's genetic, medical and applied sciences business combines a range of instruments and related reagents used to analyze deoxyribo nucleic acid (DNA) across applications in research, clinical and applied markets. It offers capillary electrophoresis (CE), quantitative polymerase chain reaction (PCR), Next Generation Sequencing (NGS) platforms and reagents. The bioproduction business supports developers and manufacturers of biological-based therapeutics and vaccines with a portfolio of solutions and services focused on upstream cell culture, downstream purification, analytics for detection and quantitation of process/product impurities. It offers single-use bioproduction solutions, production cell culture media solutions, chromatography products, rapid molecular products and solutions for the manufacture of cell therapy-based drugs.
Analytical Instruments Segment
Through the Analytical Instruments segment, the Company provides instruments, consumables, software and services that are used in the laboratory, on the production line and in the field. These products and services are used by customers in pharmaceutical, biotechnology, academic, government, environmental and other research and industrial markets, as well as the clinical laboratory. The Analytical Instruments segment includes approximately three primary businesses: Chromatography and Analytical Technologies, Mass Spectrometry, and Chemical Analysis.
The Company's chromatography and analytical technologies business provides analytical instrumentation for organic and inorganic sample analysis. These products are complemented by laboratory information management systems (LIMS); chromatography data systems (CDS); database analytical tools; automation systems, and a range of consumables, such as a line of chromatography columns. The Company's chromatography product line includes high performance liquid chromatography, ion chromatography and gas chromatography systems. Its elemental analysis spectrometers use atomic spectroscopy techniques to identify trace concentrations of elements in liquid and solid samples primarily in environmental, petrochemical, food safety, metallurgical, geochemical and clinical/toxicology research applications. Its mass spectrometry (MS) is a technique for analyzing chemical compounds, individually or in complex mixtures, by forming charged ions that are then analyzed according to their mass-to-charge ratios. The Company offers life sciences mass spectrometry systems and inorganic mass spectrometry systems, as well as a range of sample preparation and separation products including auto-samplers and multiplexing systems. Its life sciences mass spectrometers include over three product lines: triple quadrupole, ion trap and hybrid systems. Its inorganic mass spectrometers include over four product lines: isotope ratio mass spectrometry (IRMS), multi-collector mass spectrometry (MC/IRMS), inductively coupled plasma mass spectrometry (ICP/MS), and high resolution trace mass spectrometry (HR Trace/MS).
The Company's chemical analysis products fall into over five categories: materials and minerals, molecular spectroscopy, portable analytical instruments, radiation measurement and security instruments, and environmental and process instruments. Materials and minerals instruments include bench-top, production line and stand-alone systems for industrial applications. Molecular spectroscopy instruments are divided into approximately five primary techniques: Fourier transform infrared (FTIR), Raman, near-infrared (NIR), ultraviolet/visible (UV/Vis) and Nuclear Magnetic Resonance (NMR) spectroscopy. It also provides surface analysis instruments used in the semiconductor, metals, coatings and polymer industries as a product development and failure analysis tool. Its portable analytical instruments are rugged handheld products for use in the field by first responders, and law enforcement and military personnel. Its radiation measurement and security products are used to monitor, detect and identify specific forms of radiation and trace explosives in nuclear power, environmental, industrial, medical and security applications. Its environmental and process instruments include fixed and portable instrumentation used in process monitoring applications. In addition, the Company offers specialized services through its Unity Lab Services team, including equipment servicing, instrument calibration services, asset management and training.
Specialty Diagnostics segment
The Specialty Diagnostics segment offers diagnostic test kits, reagents, culture media, instruments and associated products in order to serve customers in healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. This segment has approximately six primary businesses: Clinical Diagnostics, ImmunoDiagnostics, Microbiology, Anatomical Pathology, Transplant Diagnostics and Healthcare Market Channel.
The Company's clinical diagnostics products include a range of liquid, ready-to-use and lyophilized immunodiagnostic reagent kits, calibrators, controls and calibration verification fluids. It provides products used for drugs-of-abuse testing; therapeutic drug monitoring, including immunosuppressant drug testing; thyroid hormone testing; serum toxicology; clinical chemistry; immunology; hematology; coagulation; glucose tolerance testing; first trimester screening; tumor markers testing; and biomarkers testing for sepsis, acute myocardial infarction and congestive heart failure.
The Company's immunodiagnostics offerings include developing, manufacturing and marketing blood-test systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases. In addition, it offers antibody tests to diagnose autoimmune diseases, such as rheumatoid arthritis, celiac disease, lupus and scleroderma. The Company's microbiology offerings include dehydrated and prepared culture media, collection and transport systems, instrumentation and consumables to detect pathogens in blood, diagnostic and rapid direct specimen tests, quality-control products and associated products for the microbiology laboratory. These products are used to diagnose infectious disease, determine appropriate antimicrobial therapy, implement infection control programs, and detect microbial contamination of their products or manufacturing facilities. Within the food and pharmaceutical industries, these products are used to assure the safety and quality of consumer products by monitoring production environments, raw materials and products for bacterial contamination, and animal health in the dairy industry.
The Company's anatomical pathology offerings include products for cancer diagnosis and medical research in histology, cytology and hematology applications. These products include instruments, consumables and reagents for specimen collection and transport, tissue preparation, staining and immunohistochemistry assays and controls. It also provides anatomical pathology instruments, including cassette and slide labeling systems, which enable on-demand slide and cassette printing, tissue processors for same-day tissue-processing, embedding stations, microtomes and cryostats used to section tissue, and automated staining and cover slip systems used for primary and immunohistochemistry staining.
The Company's transplant diagnostics products include human leukocyte antigen (HLA) typing and testing for the organ transplant market. The Company's diagnostic tests are used by transplant centers for tissue typing, primarily to determine the compatibility of donors and recipients pre-transplant, and to detect the presence of antibodies post-transplant that can lead to transplant rejection. Its transplant diagnostic offerings include HLA typing and antibody detection assays utilizing serological, molecular, enzyme linked immunosorbent assay (ELISA), flow and multiplexing technologies.
The Company's Healthcare Market channel offerings include consumables, diagnostic kits and reagents, equipment, instruments, solutions and services for hospitals, clinical laboratories, reference laboratories, physicians' offices and other clinical testing facilities. Healthcare Market products and solutions focus on the collection, transportation and analysis of biological samples. Its product lines include anatomical pathology, molecular diagnostic and cardiac risk management solutions, blood collection devices, and a portfolio of rapid diagnostic testing kits.
Laboratory Products and Services segment
The Company's Laboratory Products and Services segment offers self-manufactured and sourced products for the laboratory. The Laboratory Products and Services segment serves the pharmaceutical, biotechnology, academic, government and other research and industrial markets, as well as the clinical laboratory through approximately five businesses: Laboratory Equipment, Laboratory Consumables, Global Chemicals, Research and Safety Market Channel, and BioPharma Services.
The Company's Laboratory Equipment products are used primarily by pharmaceutical companies for drug discovery and development and by biotechnology companies and universities for life science research to advance the prevention and cure of diseases. The Company offers equipment, accessories, and services for sample preparation, storage and protection, and analysis with product categories, including controlled temperature technologies products, growth protection and separation products, and water and laboratory products.
The Company's laboratory consumables products include plastics, glass and related equipment to support scientific research, drug discovery and development, quality and process control, and clinical and basic research and development needs. Its product categories include cell culture and bioproduction, sample preparation and storage, liquid handling, detection instruments, and specialty products and services. Its laboratory and specialty plastics include cell culture and bioproduction products. Its liquid handling consumables include an offering of laboratory pipette tips and a range of handheld and automated pipetting systems, supporting low- through high-throughput activity. Its specialty products and services include a selection of clinical specimen collection, drug-of-abuse collection kits and environmental and food-safety glass and plastic vials, bottles and containers.
The Company's Research and Safety Market channel serves academic, pharmaceutical, biotechnology, government and industrial customers. Its research products include laboratory products, capital equipment and instruments, chemicals and consumable products. Its safety products include clean room and controlled-environment supplies, personal protective equipment, firefighting, military, and first responder equipment and supplies, and environmental monitoring and sampling equipment. Its education products include science-related and laboratory products for the K-12 and secondary education market. Its Doe & Ingalls offerings include chemical distribution and supply chain services for life science and advanced technology manufacturers. It offers training, equipment servicing and asset management, and supply management personnel. It also offers scientific support services, including desktop delivery, coordination of instrument calibration and service, and on-site customer service.
The Global Chemicals consist of a range of chemicals, solvents and reagents supporting laboratory application. The portfolio includes organic chemicals used to synthesize new materials; essential laboratory chemicals used by scientists to purify, extract, separate, identify and manufacture products; high purity analytical reagents, bioreagents used in different applications, from cell growth to detailed protein analysis; chemical building blocks, reactive intermediates and screening libraries used to accelerate drug discovery, and precious metals, salts and solutions used in a range of applications.
The Company's BioPharma Services offerings include global services for pharmaceutical and biotechnology companies engaged in clinical trials, including specialized packaging, over-encapsulation, multi-lingual and specialized labeling and distribution for Phase I through Phase IV clinical trials, biological-specimen management, specialty pharmaceutical logistics, and clinical supply-chain planning and management. Its biobanking business provides temperature-controlled repository services for pharmaceutical, biotechnology, university, government, clinical and blood-processing customers. Its biobanking services business stores pharmacological and biospecimen samples at commercial sites. Additional services include inventory management, validation, business continuity, and repository management and transportation capabilities.
Thermo Fisher Scientific Inc
168 3rd Ave
WALTHAM MA 02451-7551
Company Web Links
- BRIEF-Silver Standard signs option agreement to explore Fisher Gold Project
- BRIEF-Thermo Fisher prices offering of senior notes
- Fitch Rates Thermo Fisher's USD Senior Notes Offering 'BBB'; Outlook Stable
- BRIEF-Thermo Fisher Scientific priced offering of 1 bln euros aggregate principal amount of 0.75 percent senior notes due 2024
- Fitch Rates Thermo Fisher's EUR1.6B Senior Notes 'BBB'; Outlook Stable